Clinical Trial Update: Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

View source ↗

Summary

A prospective study evaluating the cementless anatomic femoral stem Minimax (Launay) for hip arthroplasty, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Developmental Dysplasia of the Hip
• Fracture of the Femoral Head
• Osteoarthritis
• Rheumatoid Arthritis
• Traumatic Arthritis

Snippet

Sponsor: Medacta International SA | Conditions: Primary Osteoarthritis, Secondary Osteoarthritis | Status: ACTIVE_NOT_RECRUITING